Compare ARMP & ANGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMP | ANGI |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.7M | 198.7M |
| IPO Year | 1996 | 2017 |
| Metric | ARMP | ANGI |
|---|---|---|
| Price | $5.38 | $4.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $15.00 | ★ $17.00 |
| AVG Volume (30 Days) | 82.8K | ★ 764.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1242.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $736,386,000.00 |
| Revenue This Year | N/A | $3.25 |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 47.60 |
| 52 Week Low | $2.86 | $4.26 |
| 52 Week High | $14.98 | $18.38 |
| Indicator | ARMP | ANGI |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 43.93 |
| Support Level | $5.12 | $4.55 |
| Resistance Level | $5.63 | $6.52 |
| Average True Range (ATR) | 0.44 | 0.30 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 48.63 | 19.08 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.